礼来公司调整三位关键高管职位,以优化资源配置,巩固在心脏代谢领域的地位,并加速美国与国际市场增长。新职位涉及美国及全球客户能力部、国际执行副总裁兼总裁以及心脏代谢健康部。此举旨在推进核心产品替尔泊肽的全球商业化,应对竞争压力,同时扩建工厂提升产能。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.